Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1Phase 1/2 1Phase 1 1

Status

Completed 14Unknown 7Terminated 5Recruiting 4Active not recruiting 2Not yet recruiting 1Approved for marketing 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gynecologic 5Breast 1

Conditions

Ovarian Neoplasms 368Uterine Cervical Neoplasms 144Carcinoma, Ovarian Epithelial 108Fallopian Tube Neoplasms 105Endometrial Neoplasms 99Breast Neoplasms 82Carcinoma, Non-Small-Cell Lung 70Neoplasms 55Stomach Neoplasms 49Melanoma 44Colorectal Neoplasms 44Neoplasm Metastasis 40Pancreatic Neoplasms 37Carcinoma, Renal Cell 36Triple Negative Breast Neoplasms 33Recurrence 31Squamous Cell Carcinoma of Head and Neck 28Lung Neoplasms 28Uterine Neoplasms 25Sarcoma 25Urinary Bladder Neoplasms 24Peritoneal Neoplasms 24Uterine Cervical Dysplasia 23Prostatic Neoplasms 23Colonic Neoplasms 23Esophageal Neoplasms 22Head and Neck Neoplasms 21Carcinoma, Transitional Cell 18Testicular Neoplasms 16Small Cell Lung Carcinoma 16

Interventions

liposomal doxorubicin 1NUC-1031 1Gemcitabine 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Terminated × Ovarian Diseases × Gynecologic × Clear all
NCT05001282 2024-08-07

A Study to Evaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)

Elucida Oncology

Phase 1/2 Terminated
79 enrolled
Gynecologic

Carcinoma, Ovarian Epithelial, Carcinoma, Fallopian Tube Neoplasms, Krukenberg Tumor, Ovarian Diseases, Ovarian Neoplasms, Recurrence, Uterine Diseases, Endometrial Neoplasms, Carcinoma, Endometrioid

NCT03029585 2021-04-27

Phase II Study of Intraperitoneal NanoPacĀ® in Patients With Ovarian Cancer

NanOlogy, LLC

Phase 2 Terminated
10 enrolled 13 charts
Gynecologic

Ovarian Diseases, Ovarian Neoplasms

NCT03146663 2021-02-21

NUC-1031 in Patients With Platinum-Resistant Ovarian Cancer

NuCana plc

Phase 2 Terminated
53 enrolled 19 charts
Gynecologic

Ovarian Diseases, Ovarian Neoplasms

NCT01292733 2016-01-20

OCEDP

Swedish Medical Center

Phase EARLY_PHASE1 Terminated
534 enrolled
BreastGynecologic

Breast Neoplasms, Ovarian Diseases, Ovarian Neoplasms

NCT01016054 2013-02-27

A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

Astellas Pharma Inc

Phase 1 Terminated
4 enrolled
Gynecologic

Carcinoma, Ovarian Diseases, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔